# Study Evaluating The Effect Of High-Fat Meal On Bioavailability And Pharmacokinetics Of Single Dose Of Moxidectin

> **NCT00736697** · PHASE1 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 54 (actual)

## Conditions studied

- Infection

## Interventions

- **DRUG:** moxidectin

## Key facts

- **NCT ID:** NCT00736697
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2011-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00736697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00736697, "Study Evaluating The Effect Of High-Fat Meal On Bioavailability And Pharmacokinetics Of Single Dose Of Moxidectin". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00736697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*